Pacira Pharmaceuticals, Inc. 4
4 · Pacira Pharmaceuticals, Inc. · Filed Mar 19, 2015
Insider Transaction Report
Form 4
Markvicka Taunia
Vice President, Commercial
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-17−8,349→ 0 totalExercise: $5.49Exp: 2020-12-28→ Common Stock (8,349 underlying) - Exercise/Conversion
Common Stock
2015-03-17$5.49/sh+8,349$45,836→ 8,579 total
Holdings
- 230(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Includes 230 shares of common stock acquired under the issuer's employee stock purchase plan in December 2014.
- [F2]The stock option vests as follows: 25% of the options vested on December 29, 2011, and the remaining options vested in successive equal monthly installments over the subsequent 36 months.